Therapeutics for Alzheimer’s disease based on the metal hypothesis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurotherapeutics

• Publication date

  2008-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.nurt.2008.05.001PMID 18625454PMCID PMC2518205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metals and Alzheimer's Disease

  2011cited by this paper
• Zinc and Copper Modulate Alzheimer Aβ Levels in Human Cerebrospinal Fluid

  2009cited by this paper
• Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.

  2009cited by this paper
• Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide

  2008cited by this paper
• Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

  2008cited by this paper
• Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.

  2008cited by this paper
• Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease 1

  2007cited by this paper
• Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.

  2007cited by this paper
• Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography

  2007cited by this paper
• Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology

  2007cited by this paper
• Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.

  2007cited by this paper
• Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.

  2007cited by this paper
• Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity

  2007cited by this paper
• Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau

  2007cited by this paper
• The aggregated state of amyloid-beta peptide in vitro depends on Cu2+ ion concentration.

  2007cited by this paper
• Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease.

  2007cited by this paper
• Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins*

  2007cited by this paper
• High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.

  2007cited by this paper
• Metallo-ROS in Alzheimer's disease: oxidation of neurotransmitters by CuII-beta-amyloid and neuropathology of the disease.

  2007cited by this paper
• ATP7A (Menkes protein) functions in axonal targeting and synaptogenesis.

  2007cited by this paper
• High‐resolution NMR studies of the zinc‐binding site of the Alzheimer's amyloid β‐peptide

  2007cited by this paper
• Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer’s disease

  2007cited by this paper
• Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.

  2007cited by this paper
• Elevated cortical zinc in Alzheimer disease

  2006cited by this paper
• Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity

  2006cited by this paper
• Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge*

  2006cited by this paper
• Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.

  2006cited by this paper
• Dimerisation of N-acetyl-l-tyrosine ethyl ester and Aβ peptides via formation of dityrosine

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Metals and Alzheimer's disease

  2006cited by this paper
• 1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution.

  2006cited by this paper
• A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo‐APP translation and processing

  2006cited by this paper
• Selective destabilization of soluble amyloid beta oligomers by divalent metal ions.

  2006cited by this paper
• Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes

  2006cited by this paper
• Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study

  2006cited by this paper
• Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.

  2006cited by this paper
• Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.

  2006cited by this paper
• Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity*

  2006cited by this paper
• Dietary copper and high saturated and trans fat intakes associated with cognitive decline.

  2006cited by this paper
• Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease

  2006cited by this paper
• Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration.

  2006cited by this paper
• Selective destabilization of soluble amyloid β oligomers by divalent metal ions

  2006cited by this paper
• Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease

  2006cited by this paper
• Kinetic analysis of β-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing

  2006cited by this paper
• Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.

  2005cited by this paper
• The synaptic Aβ hypothesis of Alzheimer disease

  2005cited by this paper
• Methionine regulates copper/hydrogen peroxide oxidation products of Aβ

  2005cited by this paper
• Correlation of R2 with total iron concentration in the brains of rhesus monkeys

  2005cited by this paper
• NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal Neurons

  2005influential reference
• Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry.

  2005cited by this paper
• BACE1 Cytoplasmic Domain Interacts with the Copper Chaperone for Superoxide Dismutase-1 and Binds Copper*

  2005cited by this paper
• The neurobiology of zinc in health and disease

  2005cited by this paper
• Alzheimer disease beta-amyloid activity mimics cholesterol oxidase.

  2005cited by this paper
• Promotion of oxidative lipid membrane damage by amyloid beta proteins.

  2005cited by this paper
• Molecular mechanisms of cellular injury produced by neurotoxic amino acids that generate reactive oxygen species

  2005cited by this paper
• Alzheimer's disease related copper(II)- beta-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities.

  2005cited by this paper
• Dietary supplementation with (R)-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex

  2005cited by this paper
• Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques

  2005cited by this paper
• The synaptic Abeta hypothesis of Alzheimer disease.

  2005cited by this paper
• Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.

  2005cited by this paper
• Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition

  2005cited by this paper
• In vitro gamma‐secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc

  2005cited by this paper
• Alzheimer disease β-amyloid activity mimics cholesterol oxidase

  2005cited by this paper
• Oxidation of Cholesterol by Amyloid Precursor Protein and β-Amyloid Peptide*

  2005cited by this paper
• Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins

  2005cited by this paper
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-β Precursor Protein Gene*

  2004cited by this paper
• Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App.

  2004cited by this paper
• Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia

  2004cited by this paper
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

  2004cited by this paper
• Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.

  2004cited by this paper
• Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain*

  2004cited by this paper
• Peroxidase Activity of Cyclooxygenase-2 (COX-2) Cross-links β-Amyloid (Aβ) and Generates Aβ-COX-2 Hetero-oligomers That Are Increased in Alzheimer's Disease*

  2004cited by this paper
• Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease

  2004cited by this paper
• Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

  2004cited by this paper
• Iron, brain ageing and neurodegenerative disorders

  2004cited by this paper
• The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.

  2004cited by this paper
• Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution*

  2004cited by this paper
• Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease.

  2004cited by this paper
• Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid

  2004cited by this paper
• Gene knockout of amyloid precursor protein and amyloid precursor‐like protein‐2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts

  2004cited by this paper
• Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

  2003cited by this paper
• Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity

  2003cited by this paper
• In vivo reduction of amyloid-beta by a mutant copper transporter.

  2003cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• In vivo reduction of amyloid-β by a mutant copper transporter

  2003cited by this paper
• Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

  2003cited by this paper
• Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-β Peptide with Membrane Lipid*

  2003cited by this paper
• Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice

  2003cited by this paper
• Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.

  2003cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• The galvanization of β-amyloid in Alzheimer's disease

  2002cited by this paper
• Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron*

  2002cited by this paper
• Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

  2002cited by this paper
• d‐penicillamine reduces serum oxidative stress in Alzheimer’s disease patients

  2002cited by this paper
• Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

  2002cited by this paper
• Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.

  2002cited by this paper

• Metallothioneins in Neurodegenerative Diseases: Metal Homeostasis, Autoimmunity, and Therapeutic Potential

  2026cites this paper
• Advances and Therapeutic Potential of Anthraquinone Compounds in Neurodegenerative Diseases: A Comprehensive Review

  2026cites this paper
• Design and Synthesis of Tacrine-Coumarin Hybrids via Click Chemistry as Multifunctional Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

  2026cites this paper
• Protocol for quantifying the oxidative cleavage of amyloid-β using oxygen-18 isotope labeling and LC-MS/MS.

  2026cites this paper
• Novel Copper Chelators Enhance Spatial Memory and Biochemical Outcomes in Alzheimer’s Disease Model

  2025cites this paper
• Discovery of powerful multifaceted antioxidant for combating oxidative stress associated with neurodegenerative disorders

  2025cites this paper
• Cuproptosis: mechanisms and links with Alzheimer's Disease.

  2025cites this paper
• Catechol Tetrahydroisoquinolines: Synthesis, Biological Activity, and Natural Occurrence in Portulaca oleracea as Analyzed by UPLC-Q-TOF-ESI-MS/MS

  2025cites this paper
• Inter-Organelle Crosstalk in Oxidative Distress: A Unified TRPM2-NOX2 Mediated Vicious Cycle Involving Ca2+, Zn2+, and ROS Amplification

  2025cites this paper
• Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease

  2025cites this paper
• Combating multiple aetiologies of Alzheimer's disease to rescue behavioural deficits

  2025cites this paper
• Anti-alzheimer's Disease Properties of Vanillic Acid-thiazole Hybrids: Synthesis, Characterization, and Biological Evaluation

  2025cites this paper
• Subventricular Accumulation of Cu in the Aging Mouse Brain Does Not Associate with Anticipated Increases in Markers of Oxidative Stress.

  2025cites this paper
• The emerging role of cuproptosis in spinal cord injury

  2025cites this paper
• Outdoor Air Pollution, Perivascular Space Morphology, and Cognition in Preadolescence

  2025cites this paper
• Anti-inflammatory effects of 64Zn-aspartate is accompanied by cognitive improvements in rats with Aβ1-40-induced alzheimer disease

  2025cites this paper
• Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer’s Disease

  2025cites this paper
• The role of metal element exposure and oxidative stress in mild cognitive impairment: Evidence from a Shanghai elderly cohort.

  2025cites this paper
• The Chemistry of Anticancer Mononuclear and N‐Bridged Dinuclear 8‐Aminoquinoline Half‐sandwich Metal Complexes

  2025cites this paper
• Copper homeostasis and cuproptosis in Alzheimer's disease (Review)

  2025cites this paper
• A TRPM2-Driven Signalling Cycle Orchestrates Abnormal Inter-Organelle Crosstalk in Cardiovascular and Metabolic Diseases

  2025cites this paper
• A primer on copper biology in the brain

  2025cites this paper
• Zinc utilization by microglia in Alzheimer’s disease

  2024cites this paper
• Melatonin alleviates brain injury in copper-laden rats: Underlying benefits for Wilson's disease.

  2024cites this paper
• The crosstalk between mitochondrial quality control and metal-dependent cell death

  2024cites this paper
• Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.

  2024cites this paper
• Interplay between Copper, Phosphatidylserine, and α-Synuclein Suggests a Link between Copper Homeostasis and Synaptic Vesicle Cycling

  2024cites this paper
• The Role of Copper in Alzheimer’s Disease Etiopathogenesis: An Updated Systematic Review

  2024cites this paper
• Liquid–liquid phase separation in Alzheimer’s disease

  2024cites this paper
• NOX2-TRPM2 coupling promotes Zn2+ inhibition of complex III to exacerbate ROS production in a cellular model of Parkinson’s disease

  2024cites this paper
• A commentary on studies of brain iron accumulation during ageing

  2024cites this paper
• Unveiling the effect of CaCl2 on amyloid β aggregation via supercritical angle Raman and fluorescence spectroscopy and microscopy

  2024cites this paper
• Intrathecal Immunoselective Nanopheresis for Alzheimer’s Disease: What and How? Why and When?

  2024cites this paper
• Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.

  2024cites this paper
• Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective

  2024cites this paper
• Protein Aggregation and its Affecting Mechanisms in Neurodegenerative Diseases.

  2024cites this paper
• A distinct signalling circuit upregulates cytotoxic ROS production in a cellular model of Parkinson’s disease: key roles for TRPM2, Zn2+ and complex III

  2024cites this paper
• A Copper-Binding Peptide with Therapeutic Potential against Alzheimer′s Disease: From the Blood–Brain Barrier to Metal Competition

  2024cites this paper
• AChE inhibitory effect, anti-oxidant and anti-inflammatory properties of cyclen and L-Dopa related compounds: Targeting in neurodegenerative disease

  2023cites this paper
• Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Design and synthesis of ruthenium complexes and their studies on the inhibition of amyloid β (1-42) peptide aggregation.

  2023cites this paper
• The amyloid cascade hypothesis: an updated critical review.

  2023cites this paper
• Feasibility of including a phytobiotic containing cinnamon oil in the diet to reduce the occurrence of neurodegenerative changes in broiler chicken tissues

  2023cites this paper
• Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer’s Disease: Experimental and Computational Insights

  2023cites this paper
• Recent progress in the development of fluorescent probes for imaging pathological oxidative stress.

  2023cites this paper
• Design, synthesis and evaluation of OA-tacrine hybrids as cholinesterase inhibitors with low neurotoxicity and hepatotoxicity against Alzheimer’s disease

  2023cites this paper
• The use of Surface Plasmon Resonance to study the interactions of proteins involved in conformational diseases: experimental approaches for new therapeutical perspectives.

  2023cites this paper
• Electrochemical Nanopipette Sensor for In Vitro/In Vivo Detection of Cu2+ Ions.

  2023cites this paper
• Are high copper levels related to Alzheimer’s and Parkinson’s diseases? A systematic review and meta-analysis of articles published between 2011 and 2022

  2023cites this paper
• Inhibition of amyloid β1-42 peptide aggregation by newly designed cyclometallated palladium complexes.

  2023cites this paper
• Neuropathological profile of the African Giant Rat brain (Cricetomys gambianus) after natural exposure to heavy metal environmental pollution in the Nigerian Niger Delta

  2023cites this paper
• Finding the best location: Improving the anti-amyloid ability of ruthenium(III) complexes with pyridine ligands.

  2023cites this paper
• Correlation of metal ions with specific brain region volumes in neurodegenerative diseases

  2023cites this paper
• An efficient fluorescence chemosensor for sensing Zn(II) ions and applications in cell imaging and detection of Zn(II) induced aggregation of PrP(106-126) peptide

  2023cites this paper
• Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives

  2023cites this paper
• Effect of cycloastragenol and punicalagin on Prp(106-126) and Aβ(25-35) oligomerization and fibrillizaton.

  2023cites this paper
• Synthesis and Potential Dual Inhibitory Activity Against Acetylcholinesterase and Butyrylcholinesterase of Galactose‐Conjugated Isatin β‐Thiosemicarbazones

  2023cites this paper
• Air pollution, glymphatic impairment, and Alzheimer's disease.

  2023cites this paper
• From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration

  2023cites this paper
• Metals Toxicity Associated with Oxidative Stress and Altered Level of Antioxidants in the Pathogenesis of Alzheimer’s Disease

  2023cites this paper
• 1,3-thiazole Derivatives: A Scaffold with Considerable Potential in the Treatment of Neurodegenerative Diseases.

  2023cites this paper
• Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.

  2023cites this paper
• Green removal of low and high levels of Cu(II) and Cr(III) cations from concentrated saline chloride medium achieved by a mixture of N,N′-bis(salicylidene)-thiocarbohydrazide-TritonX-100 micellar system via cloud point extraction process

  2023cites this paper
• Understanding Alzheimer's Disease and its Metal Chelation Therapeutics: A Narrative Review.

  2023cites this paper
• The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

  2023cites this paper
• Emerging role of antioxidants in Alzheimer's disease: Insight into physiological, pathological mechanisms and management

  2023influential citation
• Probable Reasons for Neuron Copper Deficiency in the Brain of Patients with Alzheimer’s Disease: The Complex Role of Amyloid

  2022cites this paper
• Current understanding of metal-dependent amyloid-β aggregation and toxicity

  2022cites this paper
• Do glutathione and copper interact to modify Alzheimer's disease pathogenesis?

  2022cites this paper
• Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease

  2022cites this paper
• Molecular Insights into the Effect of Metals on Amyloid Aggregation.

  2022cites this paper
• Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges

  2022cites this paper
• The Role of Copper Homeostasis in Brain Disease

  2022cites this paper
• Trace elements and alzheimer dementia in population-based studies: A bibliometric and meta-analysis.

  2022cites this paper
• Multipronged diagnostic and therapeutic strategies for Alzheimer's disease

  2022cites this paper
• Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities

  2022cites this paper
• Non-invasive radionuclide imaging of trace metal trafficking in health and disease: “PET metallomics”

  2022cites this paper
• Therapeutic implications of glycogen synthase kinase-3β in Alzheimer’s disease: a novel therapeutic target

  2022cites this paper
• Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.

  2022cites this paper
• From Medical Biochemistry and Biophysics Karolinska Institutet, Stockholm, Sweden

  2022cites this paper
• Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease

  2022cites this paper
• Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance

  2022cites this paper
• Testing the link between isoaspartate and Alzheimer’s disease etiology

  2022cites this paper
• Effect of Sublethal Copper Overload on Cholesterol De Novo Synthesis in Undifferentiated Neuronal Cells

  2022cites this paper
• Dl-3-n-butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal-enriched protein tyrosine phosphatase/ERK/cAMP-response element-binding protein signaling pathway

  2022cites this paper
• A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives.

  2022cites this paper
• Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper

  2022cites this paper
• Spatial Distribution of Intracellular Ion Concentrations in Aggregate‐Forming HeLa Cells Analyzed by μ‐XRF Imaging

  2022cites this paper
• Recent Modifications of Anti-Dementia Agents Focusing on Tacrine and /or Donepezil Analogs.

  2022cites this paper
• Synthesis and in vitro assessment of anticholinesterase and antioxidant properties of triazineamide derivatives.

  2022cites this paper
• Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.

  2022cites this paper
• A review of the "metallome" within neurons and glia, as revealed by elemental mapping of brain tissue.

  2021cites this paper
• Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments.

  2021cites this paper
• Multi‐Targeting Tacrine Conjugates with Cholinesterase and Amyloid‐Beta Inhibitory Activities: New Anti‐Alzheimer's Agents

  2021cites this paper
• Novel sampangine derivatives as potent inhibitors of Cu2+-mediated amyloid-β protein aggregation, oxidative stress and inflammation.

  2021cites this paper
• The Effects of Redox-Active Metal Ions and Amyloid-Degrading Enzymes on the Pathology of Alzheimer's Disease

  2021cites this paper
• Construction of Spirooxindole Analogues Engrafted with Indole and Pyrazole Scaffolds as Acetylcholinesterase Inhibitors

  2021cites this paper
• Quantitative imaging of trace elements in brain sections of Alzheimer’s disease mice with laser ablation inductively coupled plasma-mass spectrometry

  2021cites this paper
• Cross-Linked Amyloid β-Protein Oligomers: A Missing Link in Alzheimer's Disease Pathology?

  2021cites this paper
• Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases

  2021cites this paper